INDOLENT T-CELL LYMPHOPROLIFERATIVE DISORDER
OF THE GI TRACT
Post-transplant lymphoproliferative disorders
following liver transplantation: incidence, risk factors and survival.
The proapoptotic protein Bax is also expressed at high levels in CD30+ cutaneous lymphoproliferative diseases and may play a crucial role in mediating apoptosis of tumor cells.9 The CD30+ cutaneous lymphoproliferative disorders
account for approximately 25% of cutaneous T-cell lymphoma cases.10 Black persons may be less affected by lymphomatoid papulosis than persons of other racial groups.
CD30+ cutaneous lymphoproliferative disorders
: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
Meloni, "Post-transplant lymphoproliferative disorders
and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients," Virology Journal, vol.
The reported clinical case is about a patient who developed CMV/EBV ventriculoencephalitis that, despite the virological response to antiviral therapy with ganciclovir and foscarnet, evolved to EBV-driven B cell lymphoproliferative disorder
that is considered a "grey disorder" (neither benign nor malignant) that usually evolves to PCNSL .
Posttransplant lymphoproliferative disorder
(PTLD) is a very grave complication of immunosuppression in transplant patients.
Cytological diagnoses were 10 lymphoproliferative disorders
, 95 adenocarcinomas, 55 squamous cell carcinoma, 25 neuroendocrine tumours, 29 metastasis from other neoplasms, 14 poorly differentiated nonsmall-cell lung cancer, and 13 other malignancies (2 mixed adenocarcinomas and neuroendocrine, 2 adenoid cystic carcinomas, 1 pleomorphic carcinoma, 1 sarcomatoid carcinoma, 1 nonspecific CTM, 3 epithelioid mesotheliomas, 1 poorly differentiated epithelioid neoplasm, 1 mesenchymal neuron neoplasm, and 1 sarcoma).
Kempf, "CD30+ lymphoproliferative disorders
: histopathology, differential diagnosis, new variants, and simulators," Journal of Cutaneous Pathology, vol.
Boyiadzis, "Primary central nervous system post-transplant lymphoproliferative disorders
following allogeneic hematopoietic stem cell transplantation," Journal of Neuro-Oncology, vol.
It has morphologic and immunophenotypic characteristics that distinguish it from the other HHV8 lymphoproliferative disorders